ABSTRACT
Objective: To explore the diagnostic value for benign and malignant pulmonary nodules using the wavelet texture features based on nonsubsampled dual-tree complex contourlet transform (NSDTCT). Methods Texture parameters based on NSDTCT and Contourlet transform were extracted from CT images of patients with pulmonary nodules. Dimension reduction of texture features was conducted with univariate analysis and Lasso regression. The support vector machine classifiers based on these texture features for benign and malignant pulmonary nodules were constructed. ROC analysis was applied to compare the two texture extraction methods. Results For NSDTCT based features, the model based on the least number of NSDTCT texture after Lasso dimension reduction was of excellent performance, with the accuracy of 98.37% in diagnosing benign and malignant lung nodules, and the AUC was 1.00. For Contourlet transform based features, the model with all extracted texture features performed well, with the accuracy of 56.05%, and the AUC was 0.73. There was significant difference of AUC of ROC curve between the two models (Z=6.430, P<0.001). Conclusion: NSDTCT texture analysis method has good performance for diagnosing lung cancer with high classification accuracy.
ABSTRACT
Objective@#Vascular endothelial growth factor A (VEGFA) was investigated as the key protein which might promote the specific metastasis progress of nasopharyngeal carcinoma.@*Methods@#Sixteen specimens of pulmonary metastasis carcinoma and counterparts in primary nasopharyngeal carcinoma tissue were collected from patients. The expression of VEGFA through immunohistochemistry was investigated.VEGFA was knocked down by siRNA in two cell lines of nasopharyngeal carcinoma (CNE-1 and 5-8F), MTT and Transwell test were used to explore the role of VEGFA in praxiology. Then shRNA was used to cultivate the stable CNE-1 cell line with down-regulated-expression of VEGFA. The nude mice models were built through tail vein injection of specific nasopharyngeal carcinoma cells, and lungs were collected to perform further metastasis analysis.@*Results@#Previous genetic studies showed that VEGFA had higher expression in metastasis tissue, and the result was validated in the present study using immunohistochemistry. The percentage of positive cells was 84.8% in pulmonary metastasis group, 51.5% in primary tissue group (t=8.639, P<0.05), average optical density was 0.154 in pulmonary metastasis group, 0.061 in primary tissue group (t=18.791, P<0.05). Low expression of VEGFA inhibited cell viability of optical density value of CNE-1 in siRNA gourp was 0.715, 0.902 in control group (t=7.274, P<0.05); 5-8F in siRNA group was 0.715, 0.935 in control group (t=7.751, P<0.05). Number counting suppressed migration of CNE-1 in siRNA group was 52 per high-power lens, 124 per high-power lens in control group (t=29.380, P<0.05), 5-8F in siRNA group was 65 per high-power lens, 155 per high-power lens in control group (t=18.181, P<0.05). Number counting invasion of CNE-1 in siRNA gourp was 38 per high-power lens, 86 per high-power lens in control group (t=27.665, P<0.05), 5-8F in siRNA group was 52 per high-power lens, 116 per high-power lens in control group (t=40.972, P<0.05) in vitro. Furthermore, knock-down of VEGFA in nasopharyngeal carcinoma reduced the pulmonary metastasis in vivo. Number counting of tumor volumes in shRNA group was 2.4, and 11.0 in control group (t=6.143, P<0.05); average optical density of immunohistochemistry in shRNA group was 0.033, and 0.176 in control group (t=15.734, P<0.05).@*Conclusions@#Results above reveal the overexpression of VEGFA in nasopharyngeal carcinoma can facilitate the pulmonary metastasis. Targeting VEGFA may provide a new biomarker of clinical study.
ABSTRACT
BACKGROUND@#Small cell lung cancer (SCLC) is highly malignant and prone to bone marrow metastasis in early stage, but its related reports are limited. This study analyzed the clinical feature, laboratory examination, treatment and prognosis of SCLC patients with bone marrow metastasis.@*METHODS@#The clinical data of 26 SCLC patients with bone marrow metastasis were analyzed retrospectively. Prognostic factors were evaluated.@*RESULTS@#The median age of 26 patients was 57 years and the median time from diagnosis of SCLC to confirmed bone marrow metastases was 8 d. Most patients (96.2%) were accompanied by other organ metastases. The most common laboratory abnormalities were elevated lactate dehydrogenase in 19 cases (73.1%), thrombocytopenia and elevated alkaline phosphatase respectively in 11 cases (42.3%) and anemia in 7 cases (26.9%). Twenty patients had received chemotherapy and the remaining 6 patients had not. Of this group, 16 patients received at least 2 cycles of chemotherapy after the diagnosis of bone marrow metastasis. The median survival time was 15.7 wk (0.1 wk-82.9 wk) after diagnosis of bone marrow metastasis. The survival of patients with chemotherapy was significantly better than that of those without chemotherapy (χ²=33.768, P<0.001). Multivariate analysis showed that no chemotherapy was independent poor prognostic factors (P<0.05).@*CONCLUSIONS@#The SCLC patients with bone marrow metastasis have short survival, whereas chemotherapy can extend the survival of patients.
Subject(s)
Aged , Female , Humans , Male , Middle Aged , Bone Marrow , Pathology , Bone Marrow Neoplasms , Mortality , Pathology , Lung Neoplasms , Pathology , Neoplasm Metastasis , Retrospective Studies , Small Cell Lung Carcinoma , PathologyABSTRACT
Objective To explore the changes and clinical significances of serum vascular endothelial growth factor (VEGF) and endostatin concentrations for early detection of lung cancer in elderly long-term smokers. Methods Serum VEGF and endostatin concentrations were determined in 52 elderly long-term smokers and 20 elderly non-smokers by enzyme linked immunoabsent assay (ELISA) or competitive enzyme immunoassay. The 52 elderly long-term smokers were divided into lung cancer group (n = 32) and non-lung cancer group (n = 20). Results The concentration of serum VEGF was markedly higher in lung cancer group [(15. 7±8. 0) ng/L] than in non-lung cancer group and normal control group (t= 13. 681, t= 9. 372, respectively, both P＜0. 01). And the level of serum VEGF was significantly higher in non-lung cancer group than in normal control group (t=5. 250, P＜0. 05). The level of serum endostatin was significantly higher in elderly long-term smokers with or without lung cancer than in normal control group (t=5. 332, t=3. 700, respectively, P＜0. 01 and P＜0.05). But there was no statistic difference between non-lung cancer group and lung cancer group (t = 0. 814, P＞ 0.05 ). Notably, the endostatin/VEGF ratio was lower in lung cancer group than in non-lung cancer group and normal control group (t= 6. 270, t= 7. 138, respectively, both P＜0.01), while there was no significant difference between non-lung cancer group and normal control group (t= 1. 022, P＞0.05). Conclusions These findings suggest that the periodic detection of serum VEGF and endostatin and endostatin/VEGF ratio, especially endostatin/VEGF ratio, is of clinical importance and can be used as an early diagnostic marker of lung cancer in elderly long-term smokers.
ABSTRACT
Objective To study the gene expression patterns in human lung squamous cell carcinoma and adenocarcionma with cDNA chip.Methods The mRNA was extracted from cancer tissue and normal lung tissue,and then was labeled by Cy5-dCTP or Cy3-dCTP.The mixed probes were hybridized to cDNA chip containing 4096 genes and to study the gene expression patterns in lung squamous cell carcinoma and adenocarcionma.Results Seventeen genes were up-regulated and 19 genes were down-regulated in both lung squamous cell carcinoma and adenocarcinoma,the expression of 20 genes were remarkable higher in squamous cell carcinoma than that in adenocarcinoma and the expression of 14 genes were remarkable lower in squamous cell carcinoma than that in adenocarcinoma.Conclusion Many genes are possibly involved in the initiation and progression of human lung cancer;cDNA chip technique might be a useful method in screening lung cancer implicated genes.
ABSTRACT
Purpose:To study the clinical value of preoperative examination of P16 protein , immunohistochemical method was used to examinate the expression of the protein in tissues obtained through the fibrobronchoscopic brushing and biopsy.Methods:All of the patients who found lesions of lung by radiology were gotten the fibrobronchoscopy to get the spicements. All of the specimens were examinted for expression of P16 protein. The expressions of P16 protein in lung carcinoma group , benign lung disease group and blind biopsy group were compared.Results:The positive expression rates of p16 protein of lung carcinoma group , lung benign disease group and blind biopsy groups are : 55.0%, 95.0% and 62.5%. Conclusions:Difference was found between malignant and benign lung diseases.Examination of p16 protein expression for blind biopsy groups has some values in diagnosis of lung carcinoma.
ABSTRACT
0.05), especially the survival rate of stage ⅢA disease.Conclusions Concurrent chemoradiotherapy seems to be better than the sequential counter part for NSCLC,without 3 increasing the toxicity.
ABSTRACT
Objective:To study correlation of degree spiral CT enhancement and ultrastruction and density microvessel in peripheral lung cancer.Methods:31 cases of peripheral lung cancer comfirmed by operatien and pthology were examined with spiral computed tomography of enhancement with iodiated contrast meaterial before operaton.Ultrastructure and density microvessels were observed by transmission electron microscope and immunohistochemical method by factor Ⅷ on the specimens of the resected tumors.Results:①A increase in microvessel permeability of lung cancer resulted from gap between endotheliums of microvessel,lack of basement membrane of cracking,large cancer cell space.②The degree of spiral CT enhancement was correlated with microvessel density in peripheral lung cancer(r=0.926,?